Press "Enter" to skip to content

Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India

"Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark ‘Zucator’ in India," Glenmark Pharma said in a regulatory filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/glenmark-torrent-pharma-ink-licensing-pact-to-co-market-diabetes-drug-in-india/70169931?utm_source=RSS&utm_medium=ETRSS

Also Read:   Sanofi joins forces with U.S. to advance a novel coronavirus vaccine